Independent
Tenure on this board
21.0 yrs
3 nominees · 3 ballot items.
Elect three Class II directors; ratify CBIZ CPAs P.C. as independent auditors for fiscal 2026; and approve, by non-binding advisory vote, the compensation of the company’s named executive officers (Say-on-Pay).
Elect three Class II directors (Thomas J. Errico, M.D.; James C. Theofilos; and Elena Bonfiglioli) to the Board for a three-year term expiring at the 2029 annual meeting.
Ratify the selection of CBIZ CPAs P.C. as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.
Advisory (non-binding) vote to approve the compensation of the company’s named executive officers as disclosed in this proxy statement.
This advisory Say-on-Pay proposal asks shareholders to approve, on a non-binding basis, the disclosed compensation of the company’s named executive officers (NEOs). Management is seeking this vote to give shareholders an opportunity to express their views on executive pay practices and to satisfy the disclosure and governance requirements of Section 14A, while enabling the Board and compensation committee to assess shareholder sentiment. The disclosure shows a mix of cash (base salary and discretionary bonuses), equity-based incentives (restricted stock units and option grants) and severance arrangements, with recent changes including discretionary bonuses paid partially in equity, new RSU awards to executives, and a severance policy that provides for cash and equity treatment upon termination or change in control. Company-specific context: the former CEO retired and is providing transition services, an Interim President/acting CFO has been appointed, and compensation decisions have been overseen by a compensation committee composed of independent directors; the filing notes both efforts to align pay with long-term shareholder value and that “Compensation Actually Paid” has varied materially due to equity valuation changes. Management’s rationale for recommending FOR emphasizes alignment of executive interests with stockholders through equity awards, retention and transition considerations, and the committee’s governance processes (e.g., review of comparative market data, compensation committee oversight and a newly adopted compensation recovery policy). Countervailing factors for shareholders to weigh include the non-binding nature of the vote, the significant role of discretionary bonuses and equity valuation effects on reported pay-versus-performance metrics, and recent corporate changes (CEO retirement and consultant arrangements) that affect retention and severance dynamics. The Board commits to review the vote outcome and consider it in future compensation design, and the committee retains discretion to adjust pay elements to better align incentives with performance. Given the company’s small reporting-company status, the compensation program relies on a mix of short- and long-term incentives to retain talent and drive value, but shareholders should consider the historical volatility in “Compensation Actually Paid” driven by stock price movements when assessing alignment. Overall, the proposal is a governance-level ratification of disclosed pay practices rather than a change to policy, and a FOR vote signals shareholder support for the Board’s current compensation philosophy and recent awards while a negative vote would trigger a closer review and potential adjustments by the compensation committee.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT LLC | 2.35% | 211,639 | $2M |
| 2 | FourWorld Capital Management LLC | 1.04% | 94,000 | $812K |
| 3 | WEXFORD CAPITAL LP | 1.02% | 92,060 | $795K |
| 4 | GEODE CAPITAL MANAGEMENT, LLC | 0.67% | 60,043 | $519K |
| 5 | NORTHERN TRUST CORP | 0.57% | 51,439 | $444K |
| 6 | Wealthspire Advisors, LLC | 0.53% | 47,498 | $410K |
| 7 | JANE STREET GROUP, LLC | 0.50% | 44,650 | $386K |
| 8 | CITADEL ADVISORS LLC | 0.47% | 42,521 | $367K |
| 9 | MARSHALL WACE, LLP | 0.45% | 40,751 | $352K |
| 10 | VANGUARD FIDUCIARY TRUST CO | 0.43% | 38,770 | $335K |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.